መነሻ › ስቴቶቲክ የጉበት በሽታ › አሪዞና
በአሪዞና ለስቴቶቲክ የጉበት በሽታ የሚደረጉ ክሊኒካዊ ጥናቶች
ለስቴቶቲክ የጉበት በሽታ የሚደረጉ 14 ጥናቶች በአሪዞና ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በአሪዞና ውስጥ ያሉ ከተሞች
Official study text (English)
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Chandler
- 89bio Clinical Study Site, Peoria
- 89bio Clinical Study Site, Phoenix
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06419374A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chandler
- 89bio Clinical Study Site, Glendale
- 89bio Clinical Study Site, Sun City
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT06318169A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- Arizona Liver Health - Tucson, Tucson
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07527910Early Tracking of Childhood Health Determinants (ETCHED) Study
- NIDDK, Phoenix, Phoenix
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
1 Day – 99 Years · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT03481829A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Arizona Liver Health, Chandler
- The Institute for Liver Health II LLC DBA Arizona Liver Health - Peoria, Peoria
- Adobe Clinical Research, Tucson
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- The Institute for Liver Health II dba Arizona Clinical Trials - Chandler, Chandler
- Spectrum Research Institute, Gilbert
- The Institute for Liver Health II dba Arizona Liver Health - Peoria, Peoria
- እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Chandler
- Akero Clinical Study Site, Peoria
- Akero Clinical Study Site, Scottsdale
- እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 80 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06528314A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Arizona Liver Health, Chandler
- Arizona Liver Health - Peoria, Peoria
- Adobe Clinical Research, LLC, Tucson
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ9 ሴፕቴ 2026 · NCT07288138A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Chandler
- GSK Investigational Site, Phoenix
- GSK Investigational Site, Tucson
- እና 1 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT06613698Fibrosis Lessens After Metabolic Surgery
- Banner Health Center, Phoenix
ተሳታዮችን በመፈለግ ላይደረጃ 4ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ31 ጁላይ 2026 · NCT06374875A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- GSK Investigational Site, Chandler
- GSK Investigational Site, Tucson
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ27 ጁላይ 2026 · NCT07221227A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
- GSK Investigational Site, Chandler
- GSK Investigational Site, Mesa
- GSK Investigational Site, Tucson
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ8 ጁላይ 2026 · NCT06920043Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- Arizona Liver Health, Chandler
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ19 ሜይ 2026 · NCT04054310Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
- Mayo Clinic in Arizona, Scottsdale
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ30 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ28 ጃንዩ 2026 · NCT04232566ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።